JP Morgan Chase’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
JP Morgan Chase's MTRI Position: Q2 2021 in Review
JP Morgan Chase sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q2 2021, closing a stake of 1 share — an estimated $36K sold.
JP Morgan Chase first reported a position in MTRI in Q4 2020 and held it in 2 quarters. The position peaked at $36K in Q1 2021. 4 funds tracked by Wall St. Rank hold MTRI as of Q2 2021.
- JP Morgan Chase reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
- JP Morgan Chase sold 1 Mentari Therapeutics, Inc. Common Stock share in Q2 2021, an estimated $36K.
- JP Morgan Chase first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
- JP Morgan Chase's Mentari Therapeutics, Inc. Common Stock position peaked at $36K in Q1 2021.
- 4 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q2 2021.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.